Please assess the completion status of the following clinical trial:

Trial Title: Observational Study of Lyzme5 Impact on Cholesterol and Body Weight in Man

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* At least 21 years of age or older;~* Able to read, understanding, and signing a consent form;~* Not pregnant or breast feeding (female only);~* Have normal bio-markers for liver and kidney function (determined by blood test);~* Being at least 15 lbs over your ideal weight as defined by the Body Mass Index \[BMI\] chart;~* Have a total cholesterol level of or in excess of 200 mg/dl (determined by blood test);~* Not using any illegal substances, including marijuana (medicinal or otherwise);~* Not using any recreational drugs~* Weighing less than 300 lbs~Exclusion Criteria:~* Under 21 years of age;~* Mentally impaired;~* Pregnant or breast feeding;~* A diabetic;~* Having digestion problems;~* Problems with kidneys, heart, or liver;~* Having, or have had cancer;~* Taking a prescription;~* Weight of 300 lbs or over;~* Total cholesterol under 200 mg/dl;~* Using recreational drugs.

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Overweight, elevated total cholesterol (Type: PLACEBO_COMPARATOR): All individuates enrolled in this study are at least 15 lbs over their ideal weight as described on a BMI chart. Each individual must also have a total cholesterol of at least 200 mg/dl, or higher.

Based on this trial design, predict the completion outcome and termination type (if applicable).